Bluefinch Pharmaceuticals Private Limited
About Bluefinch Pharmaceuticals Private Limited
Data last updated:
Bluefinch Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 29 May 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24110WB2018PTC226330. Its GSTIN is 19AAHCB8530E1ZO (West Bengal).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Biswajit Chakraborty and Anindya Giri.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bhartia Enclave F/ No – F Ground Floor 33 V.I.P Road Kaikhali, Kolkata, West Bengal, India – 700052.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.09 Lakh, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹4,990 (net margin 0.3%) and EBITDA of ₹7,590 (EBITDA margin 0.5%). Revenue has grown at a compounded annual rate (CAGR) of 2% over five years.
Company details
Contact details
Bluefinch Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address is in the company report.
- Email
- Registered AddressBhartia Enclave F/ No – F Ground Floor 33 V.I.P Road Kaikhali, Kolkata, West Bengal, India – 700052
- IndustryChemicals, Manufacturing, Basic Chemical, Basic Chemicals Except Fertilizers And Nitrogen Compounds
To see the full contact details of Bluefinch Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bluefinch Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Bluefinch Pharmaceuticals Private Limited, buy the company report.
Financials of Bluefinch Pharmaceuticals Private Limited
FY 2025 filings availableBluefinch Pharmaceuticals Private Limited reported revenue of ₹15.09 Lakh (down 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 3% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA rose 631% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7,590 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4,990 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.5% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bluefinch Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bluefinch Pharmaceuticals Private Limited
Bluefinch Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Biswajit Chakraborty | Director | 29 May 2018 | 8 Years 5 Months | Current |
| Anindya Giri | Director | 29 May 2018 | 8 Years 5 Months | Current |
| Munmun Chakraborty | Director | 29 May 2018 | 8 Years 5 Months | Current |
Peer comparison
Bluefinch Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Panorama Pharmaceuticals Private Limited | ₹15.24 Lakh (FY 2024) | -41.0% | Hyderabad, Telangana, India | |||
| Ujiri Pharmaceuticals Private Limited | ₹15.21 Lakh (FY 2025) | -17.0% | Faridabad, Haryana, India | |||
| Bluefinch Pharmaceuticals Private Limitedthis company | ₹15.09 Lakh (FY 2025) | ₹4,990 | 0.3% | -3.0% | Kolkata, West Bengal, India | |
| Kalysta Pharmaceuticals Private Limited | ₹15.06 Lakh (FY 2018) | Mumbai, Maharashtra, India |
To see the full peer comparison of Bluefinch Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bluefinch Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bluefinch Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bluefinch Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAHCB8530E1ZO | West Bengal | Active | 29 Oct 2018 |
To see the full GST registrations and return filing status of Bluefinch Pharmaceuticals Private Limited, buy the company report.
Recent activity
Bluefinch Pharmaceuticals Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Anindya Giri was appointed as Director on 29 May 2018.
Frequently asked questions
Bluefinch Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 29 May 2018 (8+ years old) and is registered under CIN U24110WB2018PTC226330.
Bluefinch Pharmaceuticals has 3 current directors:
- Biswajit Chakraborty - Director
- Anindya Giri - Director
- Munmun Chakraborty - Director
The latest financial statements of Bluefinch Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Bluefinch Pharmaceuticals is 19AAHCB8530E1ZO, registered in West Bengal.
The CIN (Corporate Identification Number) of Bluefinch Pharmaceuticals is U24110WB2018PTC226330. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bluefinch Pharmaceuticals was incorporated on 29 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Bluefinch Pharmaceuticals by revenue are Panorama Pharmaceuticals Private Limited, Ujiri Pharmaceuticals Private Limited, Kalysta Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Anindya Giri was appointed as Director on 29 May 2018. Biswajit Chakraborty was appointed as Director on 29 May 2018. Munmun Chakraborty was appointed as Director on 29 May 2018.
The registered office of Bluefinch Pharmaceuticals is at Bhartia Enclave F No – F Ground Floor 33 V.I.P Road Kaikhali, Kolkata, West Bengal, India – 700052.
Bluefinch Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Bluefinch Pharmaceuticals can be reached at its registered office: Bhartia Enclave F No – F Ground Floor 33 V.I.P Road Kaikhali, Kolkata, West Bengal, India – 700052.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
